What is a peptide certificate of analysis?+
A certificate of analysis is a testing document for a product sample, lot, or batch. It may describe identity, strength, purity, impurities, or other tests, but it does not by itself prove a product is prescribed, sterile, correctly labeled, clinically appropriate, or safe for a specific patient.
Does a COA make research-use peptides safe for people?+
No. Research-use labeling and no-prescription peptide sales are red flags for human treatment. A COA does not replace clinician evaluation, prescription requirements, legitimate pharmacy sourcing, patient-specific labeling, storage instructions, or side-effect follow-up.
Is third-party testing enough for compounded peptides?+
No. Testing can be one quality signal, but compounded medications are not FDA-approved finished drug products. Patients should also ask about clinician review, pharmacy identity, active ingredient, route, storage, beyond-use date, adverse-event handling, and alternatives.
What should I ask if a clinic advertises peptide purity?+
Ask whether the testing matches the exact lot dispensed to you, what tests were performed, which lab performed them, how the pharmacy verifies sterility or handling when relevant, and how the label, storage, replacement, and follow-up pathways work.
Can I use a COA to compare semaglutide or tirzepatide sellers?+
Do not use COAs to shop around no-prescription GLP-1 sellers. Compare legitimate care pathways instead: FDA-approved branded products when appropriate, clinician-reviewed compounded prescriptions when legally available, pharmacy accountability, clear labels, cost transparency, and follow-up.
What peptide COA claims are red flags?+
Be cautious with vague batch numbers, screenshots, missing testing dates, unverifiable labs, research-use labels, no pharmacy name, no prescription requirement, dosing charts, guaranteed outcomes, bulk stacks, and claims that compounded finished products are FDA-approved.